The disease is always preceded by a premalignant state (MBL) which shares most molecular drivers with overt CLL. In several cases, these molecular motorists continue to be regular with time. Nonetheless, clonal evolution is usually feasible and is frequently linked to exponential tumor advancement, progressive sickness and, sometimes, ailment trans